Advertisement

Meta-Analysis of Comparison of Drug-Eluting Stents and Bare-Metal Stents in Patients on Dialysis

Published:January 25, 2017DOI:https://doi.org/10.1016/j.amjcard.2016.12.036
      Coronary artery disease is common in patients with end-stage renal disease who are on hemodialysis. The efficacy and safety of evidence regarding the use of drug-eluting stents (DES) and bare-metal stents (BMS) in patients with dialysis is unclear. We searched MEDLINE, EMBASE, Science Citation Index, CINAHL, and the Cochrane CENTRAL database of controlled clinical trials for controlled trials that compare DES and BMS in dialysis patients up to June 2016. We conducted a meta-analysis across 14 eligible studies (n = 62,250 patients). In general, DES-treated patients demonstrate a lower risk of the clinical adverse events compared with those treated with BMS. Significant reduction in the incidence of death (odds ratio [OR] 0.77, CI 0.64 to 0.92) and major adverse cardiovascular events (OR 0.65, CI 0.57 to 0.74) and target lesion/vessel revascularization (OR 0.83, CI 0.73 to 0.94), and a trend toward lower OR for myocardial infarction (OR 0.95, CI 0.87 to 1.02) were noted in DES-treated patients. In conclusion, the use of DES in patients with dialysis yields significant decrease in the risk of mortality, major adverse cardiovascular events, and target lesion/vessel revascularization. Larger randomized studies are needed to confirm the results of this meta-analysis and establish the appropriate stent choice in this high-risk population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • Coresh J.
        • Culleton B.
        • Hamm L.L.
        • McCullough P.A.
        • Kasiske B.L.
        • Kelepouris E.
        • Klag M.J.
        • Parfrey P.
        • Pfeffer M.
        • Raij L.
        • Spinosa D.J.
        • Wilson P.W.
        Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical Cardiology, and epidemiology and prevention.
        Circulation. 2003; 108: 2154-2169
        • Heywood J.T.
        • Fonarow G.C.
        • Costanzo M.R.
        • Mathur V.S.
        • Wigneswaran J.R.
        • Wynne J.
        High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.
        J Card Fail. 2007; 13: 422-430
        • Yasuda K.
        • Kasuga H.
        • Aoyama T.
        • Takahashi H.
        • Toriyama T.
        • Kawade Y.
        • Iwashima S.
        • Yamada S.
        • Kawahara H.
        • Maruyama S.
        • Yuzawa Y.
        • Ishii H.
        • Murohara T.
        • Matsuo S.
        Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
        J Am Soc Nephrol. 2006; 17: 2322-2332
        • Le F.C.
        • Dambrin G.
        • Helft G.
        • Beygui F.
        • Touam M.
        • Grunfeld J.P.
        • Vacheron A.
        • Metzger J.P.
        Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting.
        Heart. 2001; 85: 556-560
        • Bangalore S.
        • Kumar S.
        • Fusaro M.
        • Amoroso N.
        • Attubato M.J.
        • Feit F.
        • Bhatt D.L.
        • Slater J.
        Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
        Circulation. 2012; 125: 2873-2891
        • Aoyama T.
        • Ishii H.
        • Toriyama T.
        • Takahashi H.
        • Kasuga H.
        • Murakami R.
        • Amano T.
        • Uetani T.
        • Yasuda Y.
        • Yuzawa Y.
        • Maruyama S.
        • Matsuo S.
        • Matsubara T.
        • Murohara T.
        Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.
        Circ J. 2008; 72: 56-60
        • Chang T.I.
        • Montez-Rath M.E.
        • Tsai T.T.
        • Hlatky M.A.
        • Winkelmayer W.C.
        Drug-eluting versus bare-metal stents during PCI in patients with end-stage renal disease on dialysis.
        J Am Coll Cardiol. 2016; 67: 1459-1469
        • Charytan D.M.
        • Varma M.R.
        • Silbaugh T.S.
        • Lovett A.F.
        • Normand S.L.
        • Mauri L.
        Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry.
        Am J Kidney Dis. 2011; 57: 202-211
        • Chen D.Y.
        • Mao C.T.
        • Tsai M.L.
        • Hsieh M.J.
        • Lin Y.S.
        • Cherng W.J.
        • Wen M.S.
        • Wang C.H.
        • Hsieh I.C.
        • Hung M.J.
        • Chen C.C.
        • Chen T.H.
        Clinical outcomes of drug-eluting stents vs. bare-metal stents in acute myocardial infarction patients under dialysis - a Nationwide Cohort Study.
        Circ J. 2016; 80: 363-370
        • Das P.
        • Moliterno D.J.
        • Charnigo R.
        • Mukherjee D.
        • Steinhubl S.R.
        • Sneed J.D.
        • Booth D.C.
        • Ziada K.M.
        Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
        J Invasive Cardiol. 2006; 18: 405-408
        • Halkin A.
        • Selzer F.
        • Marroquin O.
        • Laskey W.
        • Detre K.
        • Cohen H.
        Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
        J Invasive Cardiol. 2006; 18: 577-583
        • Ishio N.
        • Kobayashi Y.
        • Takebayashi H.
        • Iijima Y.
        • Kanda J.
        • Nakayama T.
        • Kuroda N.
        • De Gregorio J.
        • Kouno Y.
        • Suzuki M.
        • Haruta S.
        • Komuro I.
        Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients.
        Circ J. 2007; 71: 1525-1529
        • Kim B.K.
        • Oh S.
        • Jeon D.W.
        • Yang J.Y.
        • Kim J.S.
        • Park S.
        • Choi D.
        • Jang Y.
        • Hong B.K.
        • Kwon H.M.
        • Lee S.W.
        • Goh C.W.
        • Kwon K.
        • Ryu S.K.
        Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean Multicenter Angioplasty team (KOMATE) registry.
        J Interv Cardiol. 2009; 22: 411-419
        • Lee H.F.
        • Wu L.S.
        • Chan Y.H.
        • Lee C.H.
        • Liu J.R.
        • Tu H.T.
        • Wen M.S.
        • Kuo C.T.
        • Chen W.J.
        • Yeh Y.H.
        • See L.C.
        • Chang S.H.
        Dialysis patients with implanted drug-eluting stents have lower major cardiac events and mortality than those with implanted bare-metal stents: a Taiwanese Nationwide Cohort Study.
        PLoS One. 2016; 11: e0146343
        • Okada T.
        • Hayashi Y.
        • Toyofuku M.
        • Imazu M.
        • Otsuka M.
        • Sakuma T.
        • Ueda H.
        • Yamamoto H.
        • Kohno N.
        One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents.
        Circ J. 2008; 72: 1430-1435
        • Shroff G.R.
        • Solid C.A.
        • Herzog C.A.
        Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States.
        Circulation. 2013; 127: 1861-1869
        • Tsai T.T.
        • Messenger J.C.
        • Brennan J.M.
        • Patel U.D.
        • Dai D.
        • Piana R.N.
        • Anstrom K.J.
        • Eisenstein E.L.
        • Dokholyan R.S.
        • Peterson E.D.
        • Douglas P.S.
        Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.
        J Am Coll Cardiol. 2011; 58: 1859-1869
        • Yachi S.
        • Tanabe K.
        • Tanimoto S.
        • Aoki J.
        • Nakazawa G.
        • Yamamoto H.
        • Otsuki S.
        • Yagishita A.
        • Kishi S.
        • Nakano M.
        • Taniwaki M.
        • Sasaki S.
        • Nakajima H.
        • Mise N.
        • Sugimoto T.
        • Hara K.
        Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
        Am J Kidney Dis. 2009; 54: 299-306
        • Rosenblum M.A.
        • Robbins M.J.
        • Farkouh M.E.
        • Winston J.A.
        • Kim M.C.
        Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency.
        Nephron Clin Pract. 2009; 113: c198-c202
        • Hutton B.
        • Salanti G.
        • Caldwell D.M.
        • Chaimani A.
        • Schmid C.H.
        • Cameron C.
        • Ioannidis J.P.
        • Straus S.
        • Thorlund K.
        • Jansen J.P.
        • Mulrow C.
        • Catala-Lopez F.
        • Gotzsche P.C.
        • Dickersin K.
        • Boutron I.
        • Altman D.G.
        • Moher D.
        The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
        Ann Intern Med. 2015; 162: 777-784
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • Mulrow C.
        • Gotzsche P.C.
        • Ioannidis J.P.
        • Clarke M.
        • Devereaux P.J.
        • Kleijnen J.
        • Moher D.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
        BMJ. 2009; 339: b2700
        • Stroup D.F.
        • Berlin J.A.
        • Morton S.C.
        • Olkin I.
        • Williamson G.D.
        • Rennie D.
        • Moher D.
        • Becker B.J.
        • Sipe T.A.
        • Thacker S.B.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • Charytan D.
        • Kuntz R.E.
        The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.
        Kidney Int. 2006; 70: 2021-2030
        • Coca S.G.
        • Krumholz H.M.
        • Garg A.X.
        • Parikh C.R.
        Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.
        JAMA. 2006; 296: 1377-1384
      1. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
        Am J Kidney Dis. 2005; 45: S1-S153
        • Ishii H.
        • Toriyama T.
        • Aoyama T.
        • Takahashi H.
        • Tanaka M.
        • Yoshikawa D.
        • Hayashi M.
        • Yasuda Y.
        • Maruyama S.
        • Matsuo S.
        • Matsubara T.
        • Murohara T.
        Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.
        Circ J. 2012; 76: 1609-1615
        • Meliga E.
        • De Benedictis M.
        • Gagnor A.
        • Conrotto F.
        • Novara M.
        • Scrocca I.
        • Varbella F.
        • Marra S.
        • Conte M.R.
        Clinical outcomes following percutaneous coronary intervention with drug-eluting stents versus bare metal stents in patients on chronic hemodialysis.
        J Interv Cardiol. 2013; 26: 351-358
        • Pippias M.
        • Stel V.S.
        • Abad D.J.M.
        • Afentakis N.
        • Herrero-Calvo J.A.
        • Arias M.
        • Tomilina N.
        • Bouzas C.E.
        • Buturovic-Ponikvar J.
        • Cala S.
        • Caskey F.J.
        • de la Nuez P.C.
        • Cernevskis H.
        • Collart F.
        • de la Torre R.A.
        • Garcia B.M.L.
        • De Meester J.
        • Diaz J.M.
        • Djukanovic L.
        • Ferrer A.M.
        • Finne P.
        • Garneata L.
        • Golan E.
        • Gonzalez F.R.
        • Gutierrez A.G.
        • Heaf J.
        • Hoitsma A.
        • Kantaria N.
        • Kolesnyk M.
        • Kramar R.
        • Kramer A.
        • Lassalle M.
        • Leivestad T.
        • Lopot F.
        • Macario F.
        • Magaz A.
        • Martin-Escobar E.
        • Metcalfe W.
        • Noordzij M.
        • Palsson R.
        • Pechter U.
        • Prutz K.G.
        • Ratkovic M.
        • Resic H.
        • Rutkowski B.
        • de Pablos C.S.
        • Spustova V.
        • Suleymanlar G.
        • Van Stralen K.
        • Thereska N.
        • Wanner C.
        • Jager K.J.
        Renal replacement therapy in Europe: a summary of the 2012 era-EDTA Registry Annual Report.
        Clin Kidney J. 2015; 8: 248-261
        • Landes U.
        • Kornowski R.
        • Assali A.
        • Vaknin-Assa H.
        • Greenberg G.
        • Lev E.I.
        • Bental T.
        Predictors of long term outcomes in 11,441 consecutive patients following percutaneous coronary interventions.
        Am J Cardiol. 2015; 115: 855-859
        • Tomai F.
        • Ribichini F.
        • De Luca L.
        • Petrolini A.
        • Ghini A.S.
        • Weltert L.
        • Spaccarotella C.
        • Proietti I.
        • Trani C.
        • Nudi F.
        • Pighi M.
        • Vassanelli C.
        Randomized comparison of Xience V and multi-link vision coronary stents in the same multivessel patient with chronic kidney disease (RENAL-DES) study.
        Circulation. 2014; 129: 1104-1112